ALZHEIMER’S - A NEURODEGENERATIVE DISEASE; START TO END

  • Tripti Vyas GD Memorial College of Pharmacy,Jodhpur, Rajasthan, India
  • Sidharth Mehan GD Memorial College of Pharmacy,Jodhpur, Rajasthan, India
  • Vandana Sehgal GD Memorial College of Pharmacy,Jodhpur, Rajasthan, India
  • Vivek Dave GD Memorial College of Pharmacy,Jodhpur, Rajasthan, India
  • Rimpi Arora GD Memorial College of Pharmacy,Jodhpur, Rajasthan, India
Keywords: Alzheimer’s disease; amyloid beta; Tau protein and neuroinflammation

Abstract

Alzheimer’s disease (AD) which is a progressive, irreversible, age-related, neurological and psychiatric disorder characterized by a progressive decline in memory, cognitive performance and loss of acquired skills leading to apraxia, agnosia, anomia and aphasia. The extra cellular accumulation of amyloid beta peptide, Intracellular hyperphosphorylation of Tau-proteins, Inflammatory reactions such as involvement of interleukins (IL-1 beta and TNF-alpha), excitotoxicity, oxidative stress and expression of COX and LOX are involve in the basic pathophysiology of AD. There are some neurotoxic chemicals such as streptozotocin and colchicines which are given intracerebroventricularly in rat’s brain as animal model to induce Alzheimer’s disease.
How to Cite
Tripti Vyas, Sidharth Mehan, Vandana Sehgal, Vivek Dave, & Rimpi Arora. (1). ALZHEIMER’S - A NEURODEGENERATIVE DISEASE; START TO END. International Journal of Pharma Professional’s Research (IJPPR), 2(3), 338-350. Retrieved from https://ijppronline.com/index.php/IJPPR/article/view/78
Section
Articles